More importantly, plasma MYCN/NAGK ratio is a promising, noninvasive, less time‐consuming, and repeatable method to check MYCN amplification of tumors in NB when tumor tissues are limited and MYCN nonamplification is detected in bone marrow cells by FISH test. This evidence concerns the gene NAGK and neuroblastoma.